For a variety of reasons, health care spending growth has slowed in recent years, to around 4% for each year of 2009 to 2011, which it should be noted is still much higher than economic growth. A snapshot analysis from Kaiser, with assistance from the Altarum Institute, examines whether growth is likely to continue to be moderate or will accelerate. (KFF Analysis) If the deep recession and slow recovery account for most of the decline in growth, we could anticipate that if the economy grows faster, health care spending may reaccelerate. If there really have been changes in the delivery and use of health care, then growth may remain subdued. Looking at the years 1965 through 2011, the variables that were most highly correlated with health spending were inflation in the current year and inflation in the prior two years and the growth in GDP in the current year and in the prior five years. These two variables explained 85% of the variation in health spending growth. This is amazingly predictive, and strongly suggests that economic conditions are the dominant factor in health spending increases. “Excess” health spending, however, the rate at which health spending growth is greater than potential GDP growth, has generally moderated in the last two decades, perhaps due to some systemic changes, such as greater consumer cost-sharing. Looking forward, if economic growth increases, health spending will likely follow, perhaps exacerbated by greater spending spurred by full implementation of the reform law.
Kaiser Analysis of Spending Slowdown
By Kevin RocheApril 25, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…